A considerable quantity of clinical samples has demonstrated that patients with HCC have significantly elevated serum IL-6 levels compared to healthy individuals, and these high levels of serum IL-6 are associated with a unfavorable prognosis (53). This evidence concerns the gene IL6 and hepatocellular carcinoma.